YCCI News

Brain activity related to alcohol craving and future heavy drinking is different across sexes, a new study finds, which could have implications for treatment.

More than half of human cancers, called “non-inflamed” or “cold” tumors, are not being effectively infiltrated by the cancer-fighting T cells. Essentially, the soldiers are excluded from the battlefield. Yale Cancer Center researchers want to know why.

Patients with PTSD experience both emotional numbness and hyperreactivity. A new study digs into how these contrasting symptoms are linked.

One of the largest multiomics analyses to date examines hallmarks associated with COVID-19 severity and mortality, and how these factors interact with one another.

For years, Yale School of Medicine's Kasia Lipska, MD, MHS, has been advocating for affordable pricing of insulin, an essential —and sometimes lifesaving—drug for many individuals with diabetes. Now, she is turning her attention to a similar trend of soaring prices among new diabetes and obesity medications.

A collection of recent studies from YSM

John Krystal, MD, is a leading psychiatrist who specializes in the pharmacotherapy of psychiatric disorders and a pioneering researcher into the fast-acting effects of ketamine.

Marcella Nunez-Smith is laser-focused on eliminating inequities among marginalized people.